Cara Therapeutics Statistics
Total Valuation
CARA has a market cap or net worth of $36.71 million. The enterprise value is -$21.29 million.
| Market Cap | 36.71M |
| Enterprise Value | -21.29M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CARA has 54.66 million shares outstanding. The number of shares has increased by 0.92% in one year.
| Shares Outstanding | 54.66M |
| Shares Change (YoY) | +0.92% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 14.58% |
| Owned by Institutions (%) | 45.49% |
| Float | 39.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| Forward PS | 5.54 |
| PB Ratio | 0.64 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.76.
| Current Ratio | 4.54 |
| Quick Ratio | 4.08 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -195.21 |
Financial Efficiency
Return on equity (ROE) is -122.10% and return on invested capital (ROIC) is -121.19%.
| Return on Equity (ROE) | -122.10% |
| Return on Assets (ROA) | -89.60% |
| Return on Capital (ROIC) | -121.19% |
| Revenue Per Employee | $381,236 |
| Profits Per Employee | -$2.15M |
| Employee Count | 55 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 2.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.21% in the last 52 weeks. The beta is 0.70, so CARA's price volatility has been lower than the market average.
| Beta (1Y) | 0.70 |
| 52-Week Price Change | -83.21% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 39.35 |
| Average Volume (30 Days) | 646,990 |
Short Selling Information
The latest short interest is 2.58 million, so 4.71% of the outstanding shares have been sold short.
| Short Interest | 2.58M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 4.71% |
| Short % of Float | 6.55% |
| Short Ratio (days to cover) | 3.51 |
Income Statement
In the last 12 months, CARA had revenue of $20.97 million and -$118.51 million in losses. Loss per share was -$2.19.
| Revenue | 20.97M |
| Gross Profit | 14.79M |
| Operating Income | -121.50M |
| Pretax Income | -118.51M |
| Net Income | -118.51M |
| EBITDA | -115.58M |
| EBIT | -117.91M |
| Loss Per Share | -$2.19 |
Balance Sheet
The company has $101.17 million in cash and $43.17 million in debt, giving a net cash position of $58.00 million or $1.06 per share.
| Cash & Cash Equivalents | 101.17M |
| Total Debt | 43.17M |
| Net Cash | 58.00M |
| Net Cash Per Share | $1.06 |
| Equity / Book Value | 57.09M |
| Book Value Per Share | 1.04 |
| Working Capital | 90.57M |
Cash Flow
In the last 12 months, operating cash flow was -$92.08 million and capital expenditures -$2.38 million, giving a free cash flow of -$94.45 million.
| Operating Cash Flow | -92.08M |
| Capital Expenditures | -2.38M |
| Free Cash Flow | -94.45M |
| FCF Per Share | -$1.74 |
Margins
Gross margin is 70.56%, with operating and profit margins of -579.43% and -565.21%.
| Gross Margin | 70.56% |
| Operating Margin | -579.43% |
| Pretax Margin | -565.21% |
| Profit Margin | -565.21% |
| EBITDA Margin | -551.20% |
| EBIT Margin | -562.33% |
| FCF Margin | -450.46% |
Dividends & Yields
CARA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.92% |
| Shareholder Yield | -0.92% |
| Earnings Yield | -322.86% |
| FCF Yield | -257.31% |
Analyst Forecast
The average price target for CARA is $9.79, which is 1,357.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.79 |
| Price Target Difference | 1,357.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 66.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CARA has an Altman Z-Score of -9.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.36 |
| Piotroski F-Score | 1 |